Auteur/autrice : oxeltis

OXELTIS at Bio-Europe Spring (Amsterdam-NL, March 12-14th, 2018)

Le 6 mars 201830 août 2019 par oxeltis

Oxeltis will be present at BIO-Europe Spring (March 12-14th, 2018, Amsterdam) We will be happy to meet you to discuss your current and future projects involving- medicinal chemistry (FTE contracts for Hit (...)

Toulouse Oncoweek (Feb 5-7, 2018)

Le 1 février 201830 août 2019 par oxeltis

Oxeltis will be present at OncoWeek Toulouse, looking forward meeting youcontact@oxeltis.com

RICT 2017: 53rd International Conference on Medicinal Chemistry

Le 29 juin 201730 août 2019 par oxeltis

Oxeltis will be present at RICT 2017 (Toulouse - France, July 5-7, 2017). We would be happy to invite you at Oxeltis booth to discuss your current and future projects (...)

R&D Tax Credit, 2017-2019 accreditation

Le 30 mars 201730 août 2019 par oxeltis

Oxeltis is pleased to announce to its customers and R&D partners the renewal of its agreement for R&D tax credit (agrément Crédit Impôt Recherche) by the French Ministry of Higher (...)

Oxeltis recruits 2 Post doc in Organic Synthesis / Medicinal Chemistry

Le 9 janvier 201730 août 2019 par oxeltis

Position: Post Doc (PhD) in Organic Synthesis / Medicinal Chemistry in Montpellier (France) - fix term contract 12 months, starting Feb-March 2017The Post Doc in medicinal chemistry will be responsible for (...)

BIOFIT Lille-France (29th Nov. – 1st Dec. 2016)

Le 16 novembre 201630 août 2019 par oxeltis

Oxeltis team will attend Biofit 2016 in Lille – France (29th Nov. – 1st Dec. 2016), and will be happy to meet you to discuss your current and future projects (...)

XXII International Round Table on Nucleosides, Nucleotides and Nucleic Acids

Le 1 juillet 201630 août 2019 par oxeltis

Oxeltis will be happy to meet you at the International Round Table in Paris, July 18-22, 2016 to discuss your current and future projects involving nucleoside chemistry.Oxeltis is known for– (...)

Oxeltis at Bio International convention, San Francisco, USA

Le 2 juin 201630 août 2019 par oxeltis

Oxeltis management team will be happy to meet you in San Francisco to discuss your current and future projects involving medicinal chemistry and custom synthesis.We look forward meeting you soon (...)

Oxeltis at meet2win, May 12-13, 2016, Bordeaux-FR

Le 5 mai 201630 août 2019 par oxeltis

Oxeltis is at MEET2WIN, Oncology business convention in Bordeaux May 12-13. Come to discuss your current and future projects involving medicinal chemistry (FTE contracts for Hit selection & optimization, H2L (...)

Oxeltis at ICAR, la Jolla – CA – April 17-21, 2016

Le 17 avril 201630 août 2019 par oxeltis

Oxeltis team would be happy to meet you at the 29th International Conference on Antiviral Research (ICAR 2016, La Jolla (CA-USA), April 17-21, 2016), to discuss your current and future projects involving medicinal (...)